PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma. Keggenhoff FL, Castven D, Becker D, Stojkovic S, et al. Gut 2024 Jun 10:gutjnl-2023-331237. doi: 10.1136/gutjnl-2023-331237.

Read + Share

Amedeo Smart

Independent Medical Education

Keggenhoff FL, Castven D, Becker D, Stojkovic S, et al. PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma. Gut 2024 Jun 10:gutjnl-2023-331237. doi: 10.1136/gutjnl-2023-331237.
PMID: 38857989